Changes in mandibular CDH5, CXCL1, and PECAM1 expression following exposure to bisphosphonate and molar extraction suggest a loss of vascular endothelial cell barrier integrity plays a role in MRONJ

Changes in mandibular CDH5, CXCL1, and PECAM1 expression following exposure to bisphosphonate and molar extraction suggest a loss of vascular endothelial cell barrier integrity plays a role in MRONJ

James L. Borke

College of Dental Medicine, Biomedical Sciences, Western University of Health Sciences, Pomona, California, UNITED STATES

Objectives: Medication related osteonecrosis of the jaw (MRONJ) is a disorder characterized by loss of blood supply to the jaws and death to the bone. In our previous work, we created a rat model of MRONJ by multiple injections of 60ug/Kg zoledronic acid (ZA) via tail vein followed by extraction of a single first molar. We have previously shown in this model a decrease in the vasculature of the jaws and a delay in bone healing after 6 weeks. The current study was designed to look at mRNA expression and immunohistochemical localization of three endothelial cell markers (CDH5, CXCL1 and PECAM1) 6 weeks following ZA injection with and without molar extraction and in saline injected rats as controls.  The objective of this study is to determine if the expression of these markers may serve to identify clinically significant changes in vascular endothelium barrier function associated with the onset of MRONJ.

Methods: Using RT-PCR, we analyzed the expression of mRNA for angiogenic markers, six weeks after injection with either 60ug/Kg ZA or saline as a control and in ZA injected rats following first molar extraction.  Routine immunohistochemical procedures with antibodies specific for rat marker proteins were used to study the immunohistochemical localization of proteins translated from the mRNA angiogenic markers with significant expression. All tissues were processed together under identical conditions.

Results: We found a decrease in the mRNA expression of CDH5, and PECAM1 and an increase in CXCL1 expression six weeks after extraction and ZA injection in our rat model of MRONJ.  Rat monoclonal antibodies specific for protein epitopes expressed by these genes (VE-cadherin, C-X-C motif ligand 1(CXCl1), and PECAM-1) were then used to localize proteins for these markers in tissues from ZA, saline-injected control rats, and MRONJ rats.   The results show the absence of immunohistochemical localization of PECAM-1 and VE-cadherin marker proteins (-) in tissues from the MRONJ rats but strong (++++) in tissue from the saline-injected Control rats. The results also show the localization of the immunohistochemical staining for CXCl1 was high (++++) in the MRONJ rats after six weeks but absent (-) in the Controls.  No mRNA or immunohistochemical localization for the three markers was seen in the rats treated with ZA without extraction.

Conclusions: Our study identifies markers associated with a loss of vascular endothelial cell barrier integrity suggesting a role for this mechanism in MRONJ. This finding further suggests that CDH5, CXCL1 and PECAM1 may be useful as early markers for the changes seen in blood vessels after bisphosphonate exposure but before the frank onset of MRONJ.

Keywords: bisphosphonate; osteonecrosis; medication related osteonecrosis of the jaw (MRONJ); zoledronic acid (ZA).

Free Full-text PDF

How to cite this article:

James L. Borke. Changes in mandibular CDH5, CXCL1, and PECAM1 expression following exposure to bisphosphonate and molar extraction suggest a loss of vascular endothelial cell barrier integrity plays a role in MRONJ. International Journal of Dental Research and Reviews, 2022, 5:53. DOI: 10.28933/ijdrr-2022-10-3005jlb

References:

1. Marino KL, Zakhary I, Abdelsayed RA, Carter JA, O’Neill JC, Khashaba RM, Elsalanty M, Stevens MR, Borke JL. Development of a Rat Model of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ). J Oral Implantol. 2012,38:511-518.
2. Nakasato S, Sanchez J, Chapman K, Benichou M, Fulzele S, Elo JA, Kang SY, Cuerra C, Borke JL. Selection of Angiogenic Markers that Predict the Transition from Bisphosphonate Exposure to MRONJ in a Rat Model. International Journal of Dental Research and Reviews 2018,1:6. DOI: 10.28933/ijdrr-2018-10-1801.
3. Shaik SS, Soltau TD, Chaturvedi G, Totapally B, Hagood JS, Andrews WW, Athar M, Voitenok NN, Killingsworth CR, Patel RP, Fallon MB, Maheshwari A. Low intensity shear stress increases endothelial ELR+ CXC chemokine production via a focal adhesion kinase-p38{beta} MAPK-NF-{kappa}B pathway. J Biol Chem. 2009, Feb 27;284(9):5945-55. doi: 10.1074/jbc.M807205200. Epub 2008 Dec 31. PMID: 19117939; PMCID: PMC2645838.
4. Vries MHM, Wagenaar A, Verbruggen SEL, Molin GM, Post MJ. CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space. Angiogenesis 2015; 18, 163–171. https://doi.org/10.1007/s10456-014-9454-1
5. Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol 2015, 15, 692–704. https://doi.org/10.1038/nri3908
6. Schulte D. Küppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, Vestweber D. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J, 2011; 30, 4157–4170.
7. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 2005, 105(7) 2771-2776
8. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med, 1993; 178 (2):449-460.
9. Arif N, Zinnhardt M, Nyamay’Antu A, Teber D, Brückner R, Schaefer K, Li YT, Trappmann B, Grashoff C, Vestweber D. PECAM-1 supports leukocyte diapedesis by tension-dependent dephosphorylation of VE-cadherin. EMBO J. 2021 May 3;40(9):e106113. doi: 10.15252/embj.2020106113. Epub 2021, Feb 19. PMID: 33604918; PMCID: PMC8090850.Duque GA, Descoteaux A. Macrophage Cytokines: Involvement in Immunity and Infectious Diseases Front Immunol, 2014; 5:(491) e1-12.
10. Korbecki J, Gąssowska-Dobrowolska M, Wójcik J, Szatkowska I, Barczak K, Chlubek M, Baranowska-Bosiacka I. The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System. Int J Mol Sci. 2022, Apr 11;23(8):4205. doi: 10.3390/ijms23084205. PMID: 35457023; PMCID: PMC9024980.
11. Sawant KV, Sepuru KM, Lowry E, Penaranda B, Frevert CW, Garofalo RP, Rajarathnam K. Neutrophil recruitment by chemokines Cxcl1/KC and Cxcl2/MIP2: Role of Cxcr2 activation and glycosaminoglycan interactions. J Leukoc Biol. 2021, Apr;109(4):777-791. doi: 10.1002/JLB.3A0820-207R. Epub 2020 Sep 2. PMID: 32881070; PMCID: PMC8296306